10.01.2017 Views

European Committee on Antimicrobial Susceptibility Testing

v_7.0_Breakpoint_Tables

v_7.0_Breakpoint_Tables

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Streptococcus groups A, B, C and G EUCAST Clinical Breakpoint Tables v. 7.0, valid from 2017-01-01<br />

Macrolides, lincosamides and streptogramins<br />

MIC breakpoint<br />

(mg/L)<br />

Disk<br />

c<strong>on</strong>tent<br />

Z<strong>on</strong>e diameter<br />

breakpoint<br />

(µg) (mm)<br />

S ≤ R > S ≥ R <<br />

Azithromycin 0.25 1 0.5 1 Note A Note A<br />

Notes<br />

Numbered notes relate to general comments and/or MIC breakpoints.<br />

Lettered notes relate to the disk diffusi<strong>on</strong> method.<br />

Clarithromycin<br />

Erythromycin<br />

Roxithromycin<br />

Telithromycin<br />

Clindamycin<br />

Quinupristin-dalfopristin<br />

Tetracyclines<br />

Doxycycline<br />

Minocycline<br />

Tetracycline<br />

Tigecycline<br />

Oxazolidin<strong>on</strong>es<br />

Linezolid 1<br />

Tedizolid 1 0.25 1<br />

0.25 1<br />

0.5 1<br />

0.25<br />

0.5<br />

-<br />

MIC breakpoint<br />

(mg/L)<br />

S ≤<br />

1 1<br />

0.5 1<br />

1 1<br />

0.25 3<br />

MIC breakpoint<br />

(mg/L)<br />

S ≤<br />

2<br />

0.5 2 0.5 1<br />

0.5 1<br />

1 1<br />

0.5<br />

0.5<br />

-<br />

R ><br />

2 1<br />

1 1<br />

2 1<br />

0.5 3<br />

R ><br />

4<br />

0.5<br />

Note A<br />

21 A<br />

Note A<br />

20<br />

17 B -<br />

Z<strong>on</strong>e<br />

breakpoint<br />

(mm)<br />

S ≥<br />

Note A<br />

23 A<br />

23 A<br />

19<br />

Z<strong>on</strong>e<br />

breakpoint<br />

(mm)<br />

S ≥<br />

19<br />

Note A Note A<br />

18 A<br />

Note A<br />

17<br />

17 B<br />

-<br />

diameter<br />

R <<br />

Note A<br />

20 A<br />

20 A<br />

16<br />

diameter<br />

R <<br />

16<br />

Note A 1/A. Erythromycin can be used to determine susceptibility to azithromycin, clarithromycin and roxithromycin.<br />

2. Inducible clindamycin resistance can be detected by antag<strong>on</strong>ism of clindamycin activity by a macrolide agent.<br />

then report as susceptible. If detected, then report as resistant and c<strong>on</strong>sider adding this comment to the report:<br />

still be used for short-term therapy of less serious skin and soft tissue infecti<strong>on</strong>s as c<strong>on</strong>stitutive resistance is<br />

during such therapy". The clinical importance of inducible clindamycin resistance in combinati<strong>on</strong> treatment of<br />

infecti<strong>on</strong>s is not known.<br />

B. Place the erythromycin and clindamycin disks 12-16 mm apart (edge to edge) and look for antag<strong>on</strong>ism (the<br />

detect inducible clindamycin resistance.<br />

Notes<br />

Numbered notes relate to general comments and/or MIC breakpoints.<br />

Lettered notes relate to the disk diffusi<strong>on</strong> method.<br />

1/A. Isolates susceptible to tetracycline are also susceptible to doxycycline and minocycline, but some resistant<br />

be susceptible to minocycline and/or doxycycline. An MIC method should be used to test doxycycline susceptibility<br />

resistant isolates if required.<br />

2. N<strong>on</strong>-susceptible isolates are rare or not yet reported. The identificati<strong>on</strong> and antimicrobial susceptibility test<br />

isolate must be c<strong>on</strong>firmed and the isolate sent to a reference laboratory.<br />

3. For tigecycline broth microdiluti<strong>on</strong> MIC determinati<strong>on</strong>, the medium must be prepared fresh <strong>on</strong> the day of use.<br />

Notes<br />

Numbered notes relate to general comments and/or MIC breakpoints.<br />

Lettered notes relate to the disk diffusi<strong>on</strong> method.<br />

1. N<strong>on</strong>-susceptible isolates are rare or not yet reported. The identificati<strong>on</strong> and antimicrobial susceptibility test<br />

isolate must be c<strong>on</strong>firmed and the isolate sent to a reference laboratory.<br />

2. Isolates susceptible to linezolid can be reported susceptible to tedizolid.<br />

If not detected,<br />

"Clindamycin may<br />

15<br />

unlikely to develop<br />

severe S. pyogenes<br />

15 2 2 D phenomen<strong>on</strong>) to<br />

Disk<br />

c<strong>on</strong>tent<br />

(µg)<br />

to tetracycline may<br />

30 of tetracycline<br />

30<br />

result <strong>on</strong> any such<br />

2 15<br />

Disk<br />

c<strong>on</strong>tent<br />

(µg)<br />

10 result <strong>on</strong> any such<br />

A. Isolates susceptible to linezolid can be reported susceptible to tedizolid. For isolates resistant to linezolid, perform an MIC test.<br />

33

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!